Incorporation of azide groups into an engineered Fn3 scaffold protein for site-specific, bioorthogonal conjugation.

IF 3.5 4区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Kristine T Le, Tatum R McKenna, Pauline M Mallari, Sheher-Bano Z Ahmed, Alexis M Ziemba, Maren E Buck, Sarah J Moore
{"title":"Incorporation of azide groups into an engineered Fn3 scaffold protein for site-specific, bioorthogonal conjugation.","authors":"Kristine T Le, Tatum R McKenna, Pauline M Mallari, Sheher-Bano Z Ahmed, Alexis M Ziemba, Maren E Buck, Sarah J Moore","doi":"10.1093/protein/gzag022","DOIUrl":null,"url":null,"abstract":"<p><p>Protein bioconjugates have a wide range of applications, including for targeted drug delivery and in vivo diagnostics. Expanding the chemistry available to link protein to cargo remains a critical consideration for the development of novel bioconjugates for unmet needs. Currently, most FDA-approved protein bioconjugates are based on the antibody structure, which constrains the available conjugation chemistries and applications. Alternative scaffold proteins have potential as targeting molecules that advance the synthetic possibilities. Here, we report two methods of high-yield incorporation of azide-containing groups into an Fn3 domain protein scaffold to enable click chemistry conjugation. One approach incorporates noncanonical amino acid azidohomoalanine during recombinant protein expression, and the other method develops a linker system using a unique thiol residue in the Fn3 structure. These synthetic approaches enabled orthogonal, dual labeling. The resulting conjugates retain functionality in receptor binding assays, validating these methods for diverse applications in engineering scaffold proteins for bioconjugate applications.</p>","PeriodicalId":54543,"journal":{"name":"Protein Engineering Design & Selection","volume":" ","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13480472/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Protein Engineering Design & Selection","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1093/protein/gzag022","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Protein bioconjugates have a wide range of applications, including for targeted drug delivery and in vivo diagnostics. Expanding the chemistry available to link protein to cargo remains a critical consideration for the development of novel bioconjugates for unmet needs. Currently, most FDA-approved protein bioconjugates are based on the antibody structure, which constrains the available conjugation chemistries and applications. Alternative scaffold proteins have potential as targeting molecules that advance the synthetic possibilities. Here, we report two methods of high-yield incorporation of azide-containing groups into an Fn3 domain protein scaffold to enable click chemistry conjugation. One approach incorporates noncanonical amino acid azidohomoalanine during recombinant protein expression, and the other method develops a linker system using a unique thiol residue in the Fn3 structure. These synthetic approaches enabled orthogonal, dual labeling. The resulting conjugates retain functionality in receptor binding assays, validating these methods for diverse applications in engineering scaffold proteins for bioconjugate applications.

将叠氮基团掺入工程化的Fn3支架蛋白中,用于位点特异性的生物正交偶联。
蛋白质生物偶联物具有广泛的应用,包括靶向药物传递和体内诊断。扩大可用于将蛋白质与货物连接的化学物质仍然是开发新型生物偶联物以满足未满足需求的关键考虑因素。目前,大多数fda批准的蛋白质生物偶联物是基于抗体结构的,这限制了可用的偶联化学和应用。替代支架蛋白有潜力作为提高合成可能性的靶向分子。在这里,我们报告了两种将叠氮化物基团高效结合到Fn3结构域蛋白支架中以实现点击化学偶联的方法。一种方法在重组蛋白表达过程中加入非规范氨基酸叠氮同质丙氨酸,另一种方法利用Fn3结构中独特的硫醇残基开发连接系统。这些合成方法使正交、双重标记成为可能。所得的偶联物在受体结合试验中保留了功能,验证了这些方法在生物偶联物工程支架蛋白中的不同应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Protein Engineering Design & Selection
Protein Engineering Design & Selection 生物-生化与分子生物学
CiteScore
3.30
自引率
4.20%
发文量
14
审稿时长
6-12 weeks
期刊介绍: Protein Engineering, Design and Selection (PEDS) publishes high-quality research papers and review articles relevant to the engineering, design and selection of proteins for use in biotechnology and therapy, and for understanding the fundamental link between protein sequence, structure, dynamics, function, and evolution.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书